'analyse' 검색 결과

Turns reviewer comments into structured, professional point-by-point responses linked to manuscript revisions, clarifications, rebuttals, and additional analyses.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use after writing tests to assess coverage quality across structural, mutation, requirements, and API/integration dimensions; organized knowledge for choosing and interpreting coverage analyses.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Auto-selects best Kaizen method (Gemba Walk, Value Stream, or Muda) for target

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Comprehensive A3 one-page problem analysis with root cause and action plan

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Dialogue writing and revision for screen and stage (对白/台词/潜台词) — merged from Robert McKee's Dialogue (dialogue as action, said/unsaid/unsayable, exposition as ammunition, beat = action/reaction gerunds, flaws of credibility/language/content/design, character-specific vocabulary and grammar, seven scene analyses), Richard Walter (economy, subtext, argument, no small talk, no parentheticals, silence), Neill Hicks (listening, on-the-nose exceptions, energy, five-step exercise), Lu Jun (语言要美; 典雅美/通俗美, 对话三要求 动作性/性格化/潜台词), Lajos Egri (dialogue born of three-dimensional character, escalation), Blake Snyder (cover-the-names test), and screwball-comedy dialogue conventions. Use when writing or polishing dialogue, fixing on-the-nose or expository lines, giving each character a distinct voice, converting a two-hander into a trialogue, writing comedy exchanges, or cutting speeches. Chinese-opera lyrics (戏曲唱词) are in sw-chinese-opera-banqiang, not here.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

The screenwriting business and career (编剧行业与生意经) — merged from Diamond & Weissman's Bulletproof (buyer's-eye workflow, three Cs, one-page nine-step, set pieces, submission, notes, resilience), Eric Bork's The Idea (PROBLEM seven-element idea test, 60/30/10, television differences), Neill Hicks (market four entities, six criteria, WGA, agents, option, credit arbitration, gross vs net, step deals), Richard Walter (query letter, agents, package, option, spec, release, copyright, guild, gatekeepers, professionalism, 66 principles), Wendy Henson (breaking in), Blake Snyder (logline pitch, genre, agents), Julian Hoxter (industry terms), Mei Feng's Oscar analyses, and the Hollywood masterclass (pitching, notes, credits, TV vs film). Use when evaluating whether an idea is sellable, writing a logline/query/pitch, preparing a submission, handling notes and rewrites, understanding options/credits/WGA/agents/net profit, choosing between film and TV, or building a career strategy.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Guides the creation of technical design documents before writing code, producing architecture diagrams, data models, API interface definitions, implementation plans, and multi-option trade-off analyses. Use when the user asks to plan a feature, architect a system, design an API, explore implementation approaches, or requests a technical design or spec before coding — especially for complex features involving multiple components, ambiguous requirements, or significant architectural changes.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Analyse competitor moves and translate them into strategic implications for your product roadmap. Use when a competitor announces a new feature, pricing change, partnership, or strategic shift, or when producing a periodic competitive intelligence report. Produces a categorised signal analysis with reactive-vs-proactive assessment, threat ratings, specific roadmap implications, and recommended responses with owners. For a recurring whole-market briefing use competitive-intelligence-monitor instead.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Structure a cohort analysis for retention, LTV, or behavioural patterns. Use when asked to run a cohort analysis, analyse retention by cohort, segment users by behaviour over time, or calculate lifetime value by acquisition period. Produces a complete cohort analysis framework with methodology, cohort definitions, retention curves, and prioritised interventions.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Run a 复盘 (fupan), the structured project review widely used in Chinese companies: review the goal, assess the result, analyse why, and draw rules for next time, with a blame-free tone and owned actions. Use when asked 帮我做复盘, 项目复盘, 活动复盘, 复盘会怎么开, or a fupan or retrospective in Chinese. Produces the 复盘 document in Chinese with goal versus result, root causes split into controllable and uncontrollable, lessons stated as reusable rules, and an action list with owners and dates, plus a meeting agenda.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Produce a structured budget variance analysis from actual vs budget figures. Use when asked to analyse budget variances, explain underspend or overspend, write a variance commentary, or investigate why actuals differ from plan. Produces a categorised variance table with root cause analysis and management commentary.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Analyse a construction bid or tender package for scope gaps, risk-shifting exclusions, unit-rate red flags, and front-loading in the schedule of values. Use when asked to review a bid, level bids, check a tender for gaps, compare sub quotes, or vet a schedule of values before award. Produces a structured bid review with a gap register, exclusion risk table, pricing red flags, and an award recommendation with pre-award clarifications.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Run a blameless postmortem for an incident caused by an AI agent or LLM feature — hallucinated facts shipped to users, runaway tool use, prompt injection, cost blowouts, or wrong actions taken autonomously. Use when asked to write up an AI incident, analyse why an agent did something wrong, or produce corrective actions after an LLM failure. Produces a structured postmortem with trace reconstruction, a root-cause layer analysis, and corrective actions including a permanent regression case. For non-AI production incidents use incident-postmortem.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when building the conceptual/theoretical argument of an American Anthropologist (AA) manuscript into a four-field contribution — whether the work is ethnographic, archaeological, biological, or linguistic. AA rewards a portable concept and reflexive argument over a bare finding or thick description alone. Structures the argument; it does not run analyses or write fieldnotes.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Use when analyzing the material of an Accounting, Organizations and Society (AOS) manuscript — coding and interpreting qualitative field data, estimating experimental and survey models, or running theory-laden archival analyses, with an audit trail appropriate to each tradition. Analyzes and reports; it does not design the study (aos-methods).

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Check and improve your brand's visibility across AI search engines (ChatGPT, Perplexity, Gemini, Grok, Claude, DeepSeek). Set up tracking, run visibility analyses, audit your website for AI readability, and get actionable recommendations. Uses the npx goose-aeo@latest CLI.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Generate a personal voice guide for X (Twitter) and/or LinkedIn by scanning a user's past posts and iteratively refining with sample-and-feedback loops. Produces a structured markdown voice guide that sibling skills (create-x-content, create-linkedin-content) consume to draft in-voice posts. Different from brand-voice-extractor, which analyses company blogs/landing pages — this skill is for personal social voice.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Estimates time-scaled phylogenies, molecular-clock rates, effective reproduction number R_e, and population dynamics from dated pathogen genomes using TreeTime (maximum-likelihood) and BEAST2 (Bayesian; strict/relaxed clocks; coalescent, Bayesian-Skyline, Skygrid, Birth-Death-Skyline, and sampled-ancestor priors; structured coalescent via MASCOT). Covers root-to-tip clock QC via TempEst, date-randomisation tests, recombination masking via Gubbins/ClonalFrameML before clock inference for recombining bacteria, BDSKY origin-vs-rootHeight pitfalls, sampling-bias correction, multi-chain convergence diagnostics, and reconciling phylodynamic R_e with case-based R_t. Use when dating outbreak origins, estimating substitution rates, inferring R_e through time, building time-calibrated Nextstrain Augur trees, choosing between strict and relaxed clocks, fitting Birth-Death-Skyline models, diagnosing temporal-signal failure, running MASCOT for structured-population analyses, or using UShER for pandemic-scale placement.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Queries myvariant.info BioThings aggregator for ClinVar, gnomAD, dbSNP, dbNSFP, COSMIC, CADD, and CIViC annotations in batched, version-tracked requests. Use when annotating variant lists from multiple databases simultaneously without managing per-source APIs, and when reproducibility-grade analyses require recording source data versions via _meta.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Reconstruct ancestral states at internal phylogenetic nodes for sequences (PAML codeml, IQ-TREE --ancestral, GRASP, FastML), discrete traits (corHMM hidden-rate Markov, ape::ace, phytools::make.simmap stochastic mapping, BayesTraits), and continuous traits (phytools::fastAnc, geiger Brownian/OU, RPANDA). Use when designing constructs for ancestral protein resurrection, tracing trait evolution along a tree, performing stochastic character mapping, testing models of trait evolution (BM vs OU vs EB), inferring ancestral genome content via Dollo or DTL reconciliation, or quantifying ancestral-state uncertainty for downstream comparative analyses.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Reconcile gene trees against a species tree under probabilistic models of duplication, transfer, and loss (DTL) using ALE (Szöllősi 2013 amalgamated likelihood), GeneRax (Morel 2020 ML reconciliation), AleRax (Morel 2024 co-estimation), Whale.jl (Bayesian DL+WGD), RANGER-DTL 2 parsimony, NOTUNG, ecceTERA, and Treerecs. Use when inferring ancestral gene-family content, distinguishing duplication from horizontal transfer from differential loss, rooting deep species trees from gene-content signals (STRIDE / Williams 2017 ALE-rooting), counting DTL events per branch, refining noisy gene trees against a species tree, modeling WGD events jointly with DTL, or producing publication-grade gene-family histories for phylogenomic / comparative analyses.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Build whole-genome alignments using Progressive Cactus (Armstrong 2020 reference-free clade-level WGA), Minigraph-Cactus (Hickey 2024 pangenome-aware), LASTZ chain/net (UCSC pipeline), MUMmer4 (Marçais 2018 pairwise), minimap2 -x asm5/10/20 (Li 2018 fast pairwise), AnchorWave (Song 2022 WGD-aware), and Mauve / progressiveMauve (bacterial). Operates the HAL toolkit (Hickey 2013) for downstream extraction including halSynteny, halLiftover, halBranchMutations, and hal2maf. Use when constructing multi-species alignments for comparative-annotation projection (TOGA), synteny detection, conservation analyses (phyloP / PhastCons), or pangenome graph construction; selecting between reference-free (Cactus) and reference-anchored (LASTZ chains/nets) approaches; tuning sensitivity for closely vs distantly related genomes; or producing HAL files for genome-wide downstream tools.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.